The Journal of Immunology, Vol 149, Issue 7 2385-2390, Copyright © 1992 by American Association of Immunologists

ARTICLES

Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes

SK Chai, P Clavijo, JP Tam and F Zavala
Department of Medical and Molecular Parasitology, New York University Medical Center, New York 10010.

Immunization with chemically defined synthetic polymers, multiple Ag peptide (MAP) systems, containing T and B epitopes of the circumsporozoite protein of P. berghei induce high levels of circulating antibodies that are detectable several months after boosting. The anti-MAP secondary antibody response is characterized by an increase in the levels of circulating IgG and a concomitant decrease in the IgM levels. In vitro and in vivo experiments indicated that Th epitopes included in the MAP are recognized by T cells induced after immunization with the native protein and, also, that MAP-induced T cells can recognize the native protein. In addition to high levels of anti-B epitope antibodies, MAP immunization also induces antibodies against the T epitope. This anti-T epitope immune response does not affect the generation of the anti-B epitope antibodies. Immunization of different strains of mice revealed that the antibody response is consistent with the genetically restricted pattern of recognition of the T epitope. There are, however, significant differences in the levels of antibody responses observed among responder strains. The findings of this study indicate that MAP are potent immunogens capable of inducing immunologic memory and are, thus, good candidates for the development of subunit vaccines designed to induce high levels of circulating antibodies.

This article has been cited by other articles:

				I. Petrushina, A. Ghochikyan, M. Mktrichyan, G. Mamikonyan, N. Movsesyan, H. Davtyan, A. Patel, E. Head, D. H. Cribbs, and M. G. Agadjanyan Alzheimer's Disease Peptide Epitope Vaccine Reduces Insoluble But Not Soluble/Oligomeric A{beta} Species in Amyloid Precursor Protein Transgenic Mice J. Neurosci., November 14, 2007; 27(46): 12721 - 12731. [Abstract] [Full Text] [PDF]

				J. M. Calvo-Calle, G. A. Oliveira, C. O. Watta, J. Soverow, C. Parra-Lopez, and E. H. Nardin A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite Challenge Infect. Immun., December 1, 2006; 74(12): 6929 - 6939. [Abstract] [Full Text] [PDF]

				M. G. Agadjanyan, A. Ghochikyan, I. Petrushina, V. Vasilevko, N. Movsesyan, M. Mkrtichyan, T. Saing, and D. H. Cribbs Prototype Alzheimer's Disease Vaccine Using the Immunodominant B Cell Epitope from {beta}-Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide J. Immunol., February 1, 2005; 174(3): 1580 - 1586. [Abstract] [Full Text] [PDF]

				C. M Hardy, G. Clydesdale, and K. J Mobbs Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens Reproduction, October 1, 2004; 128(4): 395 - 407. [Abstract] [Full Text] [PDF]

				B. Livingston, C. Crimi, M. Newman, Y. Higashimoto, E. Appella, J. Sidney, and A. Sette A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes J. Immunol., June 1, 2002; 168(11): 5499 - 5506. [Abstract] [Full Text] [PDF]

				K. M. Williams, E. C. Bigley III, and R. B. Raybourne Identification of Murine B-Cell and T-Cell Epitopes of Escherichia coli Outer Membrane Protein F with Synthetic Polypeptides Infect. Immun., May 1, 2000; 68(5): 2535 - 2545. [Abstract] [Full Text] [PDF]

				N. Rabinovich, P McInnes, D. Klein, and B. Hall Vaccine technologies: view to the future Science, September 2, 1994; 265(5177): 1401 - 1404. [Abstract] [PDF]